SEARCH

SEARCH BY CITATION

References

  • 1
    Aydin S, Aksoy A, Kalayci M, et al. Today's and yesterday's of pathophysiology. Biochemistry of metabolic syndrome and animal models. Nutrition 2014; 30: 19.
  • 2
    Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obesity Reviews 2012; 13: 27586.
  • 3
    Carmienke S, Freitag MH, Pischon T, et al. General and abdominal obesity parameters and their combination in relation to mortality: a systematic review and meta-regression analysis. European Journal of Clinical Nutrition 2013; 67: 57385.
  • 4
    Reaven GM. The metabolic syndrome. Requiescat in pace. Clinical Chemistry 2005; 51: 9318.
  • 5
    Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 16405.
  • 6
    Silva V, Stanton KR, Grande AJ. Harmonizing the diagnosis of metabolic syndrome – focusing on abdominal obesity. Metabolic Syndrome and Related Disorders 2013; 11: 1028.
  • 7
    Reaven G. Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation 2002; 106: 2868.
  • 8
    Canale MP, Manca di Villahermosa S, Martino G, et al. Obesity-related metabolic syndrome. mechanisms of sympathetic overactivity. International Journal of Endocrinology 2013; 2013: 865965.
  • 9
    Alvarez-Lario B, Macarron-Vicente J. Is there anything good in uric acid? Quarterly Journal of Medicine 2011; 104: 101524.
  • 10
    Pradhan G, Samson SL, Sun Y. Ghrelin: much more than a hunger hormone. Current Opinion in Clinical Nutrition and Metabolic Care 2013; 16: 61924.
  • 11
    Keen-Rhinehart E, Ondek K, Schneider JE. Neuroendocrine regulation of appetitive ingestive behavior. Frontiers in Neuroscience 2013; 7: 213.
  • 12
    Cai D, Liu T. Inflammatory cause of metabolic syndrome via brain stress and NF-kappaB. Aging 2012; 4: 98115.
  • 13
    Klop B, Elte JW, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients. 2013; 5: 121840.
  • 14
    Roberts CK, Hevener AL, Barnard RJ. Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Comprehensive Physiology 2013; 3: 158.
  • 15
    Mark AL. Selective leptin resistance revisited. American Journal of Physiology Regulatory, Integrative and Comparative Physiology 2013; 305: R56681.
  • 16
    Liesa M, Shirihai OS. Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metabolism 2013; 17: 491506.
  • 17
    Koleva DI, Orbetzova MM, Atanassova PK. Adipose tissue hormones and appetite and body weight regulators in insulin resistance. Folia Medica 2013; 55: 2532.
  • 18
    Purkayastha S, Cai D. Neuroinflammatory basis of metabolic syndrome. Molecular Metabolism 2013; 2: 35663.
  • 19
    Bremer AA, Jialal I. Adipose tissue dysfunction in nascent metabolic syndrome. Journal of Obesity 2013; 2013: 393192.
  • 20
    McGown C, Birerdinc A, Younossi ZM. Adipose tissue as an endocrine organ. Clinics in Liver Disease 2014; 18: 4158.
  • 21
    Weiss R, Bremer AA, Lustig RH. What is metabolic syndrome, and why are children getting it? Annals of the New York Academy of Sciences 2013; 1281: 12340.
  • 22
    Park JS, Seo JH, Youn HS. Gut microbiota and clinical disease: obesity and nonalcoholic fatty liver disease. Pediatric Gastroenterology, Hepatology and Nutrition 2013; 16: 227.
  • 23
    Lubrano C, Genovesi G, Specchia P, et al. Obesity and metabolic comorbidities: environmental diseases? Oxidative Medicine and Cellular Longevity 2013; 2013: 640673.
  • 24
    Benyshek DC. The “early life” origins of obesity-related health disorders: new discoveries regarding the intergenerational transmission of developmentally programmed traits in the global cardiometabolic health crisis. American Journal of Physical Anthropology 2013; 152 (Suppl 57): 7993.
  • 25
    Schwenk RW, Vogel H, Schurmann A. Genetic and epigenetic control of metabolic health. Molecular Metabolism 2013; 2: 33747.
  • 26
    Abel ED, O'Shea KM, Ramasamy R. Insulin resistance: metabolic mechanisms and consequences in the heart. Arteriosclerosis, Thrombosis, and Vascular Biology 2012; 32: 206876.
  • 27
    Huffman C, Wagman G, Fudim M, Zolty R, Vittorio T. Reversible cardiomyopathies – a review. Transplantation Proceedings 2010; 42: 36738.
  • 28
    Rask-Madsen C, Kahn CR. Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2012; 32: 20529.
  • 29
    Szasz T, Bomfim GF, Webb RC. The influence of perivascular adipose tissue on vascular homeostasis. Vascular Health and Risk Management 2013; 9: 10516.
  • 30
    Iyer SR. Sleep and type 2 diabetes mellitus – clinical implications. Journal of the Association of Physicians of India 2012; 60: 427.
  • 31
    Mandal S, Hart N. Respiratory complications of obesity. Clinical Medicine 2012; 12: 758.
  • 32
    Barranco P, Delgado J, Gallego LT, et al. Asthma, obesity and diet. Nutricion Hospitalaria 2012; 27: 13845.
  • 33
    Alicic RZ, Patakoti R, Tuttle KR. Direct and indirect effects of obesity on the kidney. Advances in Chronic Kidney Disease 2013; 20: 1217.
  • 34
    Zambo V, Simon-Szabo L, Szelenyi P, Kereszturi E, Banhegyi G, Csala M. Lipotoxicity in the liver. World Journal of Hepatology 2013; 5: 5507.
  • 35
    Kim B, Feldman EL. Insulin resistance in the nervous system. Trends in Endocrinology and Metabolism 2012; 23: 13341.
  • 36
    Guillet C, Masgrau A, Walrand S, Boirie Y. Impaired protein metabolism: interlinks between obesity, insulin resistance and inflammation. Obesity Reviews 2012; 13(Suppl 2): 517.
  • 37
    Sellam J, Berenbaum F. Is osteoarthritis a metabolic disease? Joint Bone Spine 2013; 80: 56873.
  • 38
    Rho YH, Zhu Y, Choi HK. The epidemiology of uric acid and fructose. Seminars in Nephrology 2011; 31: 4109.
  • 39
    de Heredia FP, Gomez-Martinez S, Marcos A. Obesity, inflammation and the immune system. Proceedings of the Nutrition Society 2012; 71: 3328.
  • 40
    Blokhin IO, Lentz SR. Mechanisms of thrombosis in obesity. Current Opinion in Hematology 2013; 20: 43744.
  • 41
    Catalan V, Gomez-Ambrosi J, Rodriguez A, Fruhbeck G. Adipose tissue immunity and cancer. Frontiers in Physiology 2013; 4: 275.
  • 42
    Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 2011; 54: 250614.
  • 43
    Guidone C, Manco M, Valera-Mora E, et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 2006; 55: 202531.
  • 44
    Knop FK, Taylor R. Mechanism of metabolic advantages after bariatric surgery: it's all gastrointestinal factors versus it's all food restriction. Diabetes Care 2013; 36(Suppl 2): S28791.
  • 45
    Cereda M, Neligan PJ, Reed AJ. Noninvasive respiratory support in the perioperative period. Current Opinion in Anesthesiology 2013; 26: 13440.
  • 46
    Brackbill ML, Sytsma CS, Sykes K. Perioperative outcomes of coronary artery bypass grafting: effects of metabolic syndrome and patient's sex. American Journal of Critical Care 2009; 18: 46873.
  • 47
    Gonzalez Della Valle A, Chiu YL, Ma Y, Mazumdar M, Memtsoudis SG. The metabolic syndrome in patients undergoing knee and hip arthroplasty: trends and in-hospital outcomes in the United States. Journal of Arthroplasty 2012; 27: 17439 e1.
  • 48
    Memtsoudis SG, Kirksey M, Ma Y, et al. Metabolic syndrome and lumbar spine fusion surgery: epidemiology and perioperative outcomes. Spine 2012; 37: 98995.
  • 49
    Protack CD, Bakken AM, Xu J, Saad WA, Lumsden AB, Davies MG. Metabolic syndrome: A predictor of adverse outcomes after carotid revascularization. Journal of Vascular Surgery 2009; 49: 117280 e1.
  • 50
    Turrentine FE, Hanks JB, Schirmer BD, Stukenborg GJ. The relationship between body mass index and 30-day mortality risk, by principal surgical procedure. Archives of Surgery 2012; 147: 23642.
  • 51
    Dickerson RN. The obesity paradox in the ICU: real or not? Critical Care 2013; 17: 154.
  • 52
    Rattan R, Nasraway SA Jr. Separating wheat from chaff: examining the obesity paradox in the critically ill. Critical Care 2013; 17: 168.